US Broker Ratings

Relay Therapeutics, Inc. (RLAY) Stock Analysis: A Biotech with 41.67% Potential Upside and Strong Buy Ratings

Relay Therapeutics, Inc. (NASDAQ: RLAY), a clinical-stage precision medicines company based in Cambridge, Massachusetts, has captured investor attention with its innovative approach to drug discovery, focusing..

Delcath Systems, Inc. (DCTH) Stock Analysis: Exploring a Potential 63% Upside in the Medical Devices Sector

Delcath Systems, Inc. (NASDAQ: DCTH) has emerged as a compelling player within the healthcare sector, specifically in the medical devices industry. With a market capitalization of..

Anavex Life Sciences Corp. (AVXL) Investor Outlook: Navigating the Path of Biotech Innovation

Anavex Life Sciences Corp. (NASDAQ: AVXL), a biopharmaceutical company headquartered in New York, is carving a niche in the competitive biotechnology sector with its focus on..

AMN Healthcare Services Inc (AMN) Stock Analysis: Navigating a Challenging Market with Strategic Potential

AMN Healthcare Services Inc (AMN), a key player in the healthcare staffing industry, offers a comprehensive suite of technology-enabled workforce solutions. Despite facing a challenging market..

Embecta Corp. (EMBC) Stock Analysis: Navigating a Potential -39% Downside in the Healthcare Sector

Embecta Corp. (NASDAQ: EMBC), a stalwart in the medical instruments and supplies industry, offers investors a complex mix of challenges and opportunities. Specializing in diabetes care..

Arcus Biosciences (RCUS) Stock Analysis: Exploring a 120% Potential Upside in the Biotech Space

Investors with a keen eye on the biotechnology sector might find Arcus Biosciences, Inc. (NASDAQ: RCUS) an intriguing prospect. This clinical-stage biopharmaceutical company, boasting a market..

Akso Health Group (AHG) Investor Outlook: Navigating Challenges with Strategic Potential

For individual investors seeking opportunities within the healthcare sector, Akso Health Group (NASDAQ: AHG) presents a compelling case with its diverse business model and strategic potential..

Valneva SE (VALN)

⚠️ No article content returned.

..

Maravai LifeSciences Holdings (MRVI) Stock Analysis: Navigating Biotech’s Potential with a 0.47% Upside

Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) is garnering attention in the biotechnology sector. With a market capitalization of $3.13 billion, this San Diego-based company is strategically..

Gyre Therapeutics, Inc. (GYRE): Investor Outlook with a Potential Upside of 191%

Gyre Therapeutics, Inc. (NASDAQ: GYRE) is capturing investor attention with its compelling potential upside of 191.21%, as revealed by recent analyst ratings. This figure positions Gyre..

Ardelyx, Inc. (ARDX) Stock Analysis: Unveiling a 312% Potential Upside with Strong Buy Ratings

Ardelyx, Inc. (NASDAQ: ARDX), a promising player in the healthcare sector, specifically within the biotechnology industry, is catching investors’ attention with an impressive potential upside of..

Iovance Biotherapeutics, Inc. (IOVA) Stock Analysis: Unpacking a 50% Potential Upside in the Biotech Space

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) presents a compelling opportunity within the biotechnology sector for investors looking for high-growth potential. With a market capitalization of $4.33 billion,..

Arbutus Biopharma (ABUS) Stock Analysis: Exploring a 27.82% Upside Potential

In the volatile world of biotechnology, Arbutus Biopharma Corporation (NASDAQ: ABUS) stands out as a compelling prospect for investors seeking opportunities in the healthcare sector. With..

Akebia Therapeutics, Inc. (AKBA) Stock Analysis: A 427% Upside Potential Ignites Investor Interest

For investors hunting for opportunities in the healthcare sector, Akebia Therapeutics, Inc. (NASDAQ: AKBA) presents a compelling case with its remarkable potential upside of 427.71%. This..

Syndax Pharmaceuticals, Inc. (SNDX)

⚠️ No article content returned.

..

Beta Bionics, Inc. (BBNX) Stock Analysis: 42.78% Potential Upside in the Innovative Medical Device Arena

Beta Bionics, Inc. (NASDAQ: BBNX), a pioneering force in the healthcare sector, is capturing the attention of investors with its innovative approach to diabetes management. Specializing..

Vir Biotechnology, Inc. (VIR) Stock Analysis: Unraveling a 78.72% Potential Upside for Investors

Vir Biotechnology, Inc. (NASDAQ: VIR), a clinical-stage biopharmaceutical company, has been making waves in the healthcare sector with its innovative approach to combating infectious diseases. Headquartered..

iRadimed Corporation (IRMD) Stock Analysis: Unpacking a 37.63% Potential Upside

In the ever-evolving landscape of healthcare technology, iRadimed Corporation (NASDAQ: IRMD) stands as a key player within the medical devices industry. Specializing in MRI-compatible intravenous infusion..

InMode Ltd. (INMD) Stock Analysis: A 19.66% Potential Upside in the Healthcare Sector

InMode Ltd. (NASDAQ: INMD), a prominent player in the healthcare sector specializing in medical devices, is garnering attention from investors due to its innovative approach in..

ArriVent BioPharma, Inc. (AVBP) Stock Analysis: A Promising Biotech with 61.76% Upside Potential

ArriVent BioPharma, Inc. (NASDAQ: AVBP) is making waves in the biotechnology sector as a clinical-stage company committed to advancing the treatment landscape for cancer patients. With..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds